Spontaneous pneumomedistinum & subcutaneous emphysema in idiopathic pulmonary fibrosis (IPF) with bronchial wall leak

C. Patel, R. Chopra, V. Pandharkar, A. Yannawar, J. Gaikwad, M. Bhosle, S. Patil (Pune, India)

Source: Annual Congress 2012 - Diffuse parenchymal lung disease III
Session: Diffuse parenchymal lung disease III
Session type: Thematic Poster Session
Number: 3669
Disease area: Interstitial lung diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
C. Patel, R. Chopra, V. Pandharkar, A. Yannawar, J. Gaikwad, M. Bhosle, S. Patil (Pune, India). Spontaneous pneumomedistinum & subcutaneous emphysema in idiopathic pulmonary fibrosis (IPF) with bronchial wall leak. Eur Respir J 2012; 40: Suppl. 56, 3669

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Abnormal pulmonary arterial remodelling in patients with combined pulmonary fibrosis emphysema (CPFE) and idiopathic pulmonary fibrosis (IPF)
Source: Annual Congress 2011 - Clinical approach of diffuse parenchymal lung disease
Year: 2011

Idiopathic pulmonary fibrosis (IPF)
Source: ERS Course 2016
Year: 2016




Combined pulmonary fibrosis and emphysema syndrome (CFPE)
Source: Annual Congress 2012 - Diffuse parenchymal lung disease: clinical profiles and collagen vascular disease
Year: 2012


The impact of emphysema in pulmonary fibrosis
Source: Eur Respir Rev 2013; 22: 153-157
Year: 2013



Changes in the small airways in idiopathic pulmonary fibrosis
Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis and rarities
Year: 2013

Subtypes of pulmonary emphysema on HRCT affect prognosis on combined pulmonary fibrosis and emphysema in idiopathic pulmonary fibrosis
Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: clinical view
Year: 2013


The chance of developing lung cancers are more in combined pulmonary fibrosis & emphysema than emphysema alone
Source: Annual Congress 2010 - Different patterns of interstitial lung disease
Year: 2010

Mechanism of bronchoalveolar duct junction (BADJ) remodeling in idiopathic pulmonary fibrosis (IPF) as base for new pathogenetic therapy
Source: Annual Congress 2008 - Management of idiopathic pulmonary fibrosis: what can we learn from the pathophysiology?
Year: 2008

Pulmonary vascular changes in COPD and idiopathic pulmonary fibrosis (IPF)
Source: Annual Congress 2006 - Clinical physiology
Year: 2006

Small airways impairment and air-trapping distinguish chronic hypersensitivity pneumonitis (CHP) from idiopathic pulmonary fibrosis (IPF)
Source: International Congress 2017 – ILDs: clinical problems
Year: 2017

Serum surfactant protein D (SP-D) and annual decline of diffusion capacity are prognostic factors for combined pulmonary fibrosis with emphysema (CPFE) in idiopathic pulmonary fibrosis (IPF)
Source: Annual Congress 2013 –Clinical respiratory physiology in different diseases
Year: 2013


Significance of small airway obstruction in patients with idiopathic pulmonary fibrosis.
Source: International Congress 2019 – Innovations in idiopathic pulmonary fibrosis
Year: 2019

Etablishing rhesus model of pulmonary fibrosis (PF) for the new drug evaluation
Source: International Congress 2015 – IPF: from bench to bedside
Year: 2015

Serum levels of surfactant proteins in patients with combined pulmonary fibrosis and emphysema (CPFE)
Source: International Congress 2015 – IPF pathogenesis
Year: 2015



Plasma protein signature of idiopathic pulmonary fibrosis (IPF)
Source: Annual Congress 2013 –Translational research to bridge the need within clinical decision making
Year: 2013

Ectopic subpleural fat deposition in idiopathic pulmonary fibrosis correlates with radiographic extension of fibrosis
Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: clinical view
Year: 2013

Increased apoptosis of alveolar lymphocytes (AL) in idiopathic pulmonary fibrosis (IPF). Potential mechanisms and practical considerations
Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: clinical view
Year: 2013


Complications in transbrochial cryobiopsy (TCB)
Source: International Congress 2015 – Interstitial lung diseases I
Year: 2015

Pulmonary tuberculosis (TB) as a complication of idiopathic pulmonary fibrosis (IPF)
Source: Annual Congress 2009 - A wide spectrum of idiopathic pulmonary fibrosis
Year: 2009


Neutrophil-rich inflammation in induced sputum of patients with idiopathic pulmonary fibrosis (IPF)
Source: Eur Respir J 2001; 18: Suppl. 33, 409s
Year: 2001